# Detection of dengue group viruses by fluorescence in situ hybridization.

Vincent Raquin, Martin Wannagat, Karima Zouache, Catherine Legras-Lachuer, Claire Valiente Moro, Patrick Mavingui

► To cite this version:

Vincent Raquin, Martin Wannagat, Karima Zouache, Catherine Legras-Lachuer, Claire Valiente Moro, et al. Detection of dengue group viruses by fluorescence in situ hybridization. Parasites & Vectors, 2012, 5 (1), pp.243. 10.1186/1756-3305-5-243. pasteur-00758021

HAL Id: pasteur-00758021

https://pasteur.hal.science/pasteur-00758021

Submitted on 27 Nov 2012

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Detection of dengue group viruses by
fluorescence *in situ* hybridization

Vincent Raquin<fnref n="1" />, Martin Wannagat<fnref n="1" />,², Karima Zouache³, Catherine Legras-Lachuer<fnref n="1" />, Claire Valiente Moro<fnref n="1" /> and Patrick Mavingui<fnref n="1" />*

**Abstract**

**Background:** Dengue fever (DF) and dengue hemorrhagic fever (DHF) represent a global challenge in public health. It is estimated that 50 to 100 million infections occur each year causing approximately 20,000 deaths that are usually linked to severe cases like DHF and dengue shock syndrome. The causative agent of DF is dengue virus (genus *Flavivirus*) that comprises four distinct serotypes (DENV-1 to DENV-4). Fluorescence *in situ* hybridization (FISH) has been used successfully to detect pathogenic agents, but has not been implemented in detecting DENV. To improve our understanding of DENV infection and dissemination in host tissues, we designed specific probes to detect DENV in FISH assays.

**Methods:** Oligonucleotide probes were designed to hybridize with RNA from the broadest range of DENV isolates belonging to the four serotypes, but not to the closest *Flavivirus* genomes. Three probes that fit the criteria defined for FISH experiments were selected, targeting both coding and non-coding regions of the DENV genome. These probes were tested in FISH assays against the dengue vector *Aedes albopictus* (Diptera: Culicidae). The FISH experiments were led *in vitro* using the C6/36 cell line, and *in vivo* against dissected salivary glands, with epifluorescence and confocal microscopy.

**Results:** The three 60-nt oligonucleotides probes DENV-Probe A, B and C cover a broad range of DENV isolates from the four serotypes. When the three probes were used together, specific fluorescent signals were observed in C6/36 infected with each DENV serotypes. No signal was detected in either cells infected with close *Flavivirus* members West Nile virus or yellow fever virus. The same protocol was used on salivary glands of *Ae. albopictus* fed with a DENV-2 infectious blood-meal which showed positive signals in the lateral lobes of infected samples, with no significant signal in uninfected mosquitoes.

**Conclusion:** Based on the FISH technique, we propose a way to design and use oligonucleotide probes to detect arboviruses. Results showed that this method was successfully implemented to specifically detect DENV in a mosquito cell line, as well as in mosquito salivary glands for the DENV-2 serotype. In addition, we emphasize that FISH could be an alternative method to detect arboviruses in host tissues, also offering to circumvent the discontinuity of antibodies used in immunofluorescent assays.

**Keywords:** Dengue, Virus, Fluorescence *In Situ* Hybridization, *Aedes albopictus*

<footnote>* Correspondence: patrick.mavingui@univ-lyon1.fr</footnote>

<footnote n="1">¹UMR CNRS 5557 Ecologie Microbienne, Université Lyon 1, 43 boulevard du
11 Novembre 1918, Villeurbanne cedex 69622, France</footnote>

<footnote>Full list of author information is available at the end of the article</footnote>
**Background**

Dengue fever (DF) is the most common arthropod-borne human viral disease, affecting populations of mainly tropical and sub-tropical countries. The geographic area of DF transmission has expanded considerably during recent decades, and the number of cases reported has increased more than 30-fold since the 1960s [1]. More than 50 million people are infected annually and a third of the world population is at risk of contracting the disease [2].

DF and dengue hemorrhagic fever (DHF) are caused by dengue virus (DENV), an arbovirus (arthropod-borne virus) belonging to the *Flavivirus* genus that comprises other medically important viruses such as yellow fever virus (YFV), West Nile virus (WNV), tick-borne encephalitis virus (TBEV) and Japanese encephalitis virus (JEV) [3]. The DENV nucleocapsid contains a single-stranded, positive-sense RNA genome of approximately 11 kb in length. Four antigenically distinct serotypes (DENV-1 to DENV-4) are known, defined according to cell-surface antigens detected using various serological methods [4,5]. Nucleic acid sequencing showed that within serotypes, genetically distinct groups called genotypes exist whose sequences diverge at given regions of the genome [6].

DENV are maintained in nature within two cycles. In the sylvatic cycle, non-human primates are the reservoirs and the virus is transmitted by arboreal mosquito vectors, such as *Aedes falcifer* and *Aedes luteocephalus* who have been identified as probable vectors in Senegal [7-9]. The human cycle involves highly anthropophilic vectors, mostly *Aedes aegypti* and *Aedes albopictus*, with humans as the only known reservoir and amplification host [10,11]. Tools are available to study DENV, including virus isolation that allows retrieval of particles from host samples [12], and quantitative RT-PCR to identify serotypes or genotypes and estimate virus density [13]. In addition, serological assays were developed to diagnose DENV infection among vertebrate hosts [14]. However, these methods did not allow direct visualization of DENV RNA or particles inside infected samples. Thus, they need to be completed with an *in situ* detection to fully understand the viral infection process and to explore the temporal and spatial tropism of DENV in hosts and reservoirs. Standard DENV *in situ* detection relies on direct targeting of virus particles using serotype-specific antibodies [15]. In humans, immunological detection of DENV in samples obtained from DF/DHF patients revealed virus tropism for liver, spleen, kidney, lung and phagocytic cells [16]. In mosquitoes, an immunodetection approach made it possible to decipher the DENV time course, called the extrinsic incubation period (EIP), time between ingestion of an infectious blood-meal to the infection of the salivary glands and release of the virus into the saliva [17].

Fluorescence *in situ* hybridization (FISH) is a detection method classically employed to target nucleic acids (RNA and DNA) within cells and tissues using a fluorochrome-labelled probe complementary to the target that is then observed by fluorescence microscopy [18]. The increasing range of available fluorochromes, the development of new bioinformatics tools assisting probe design, and improvements in fluorescence microscopy and imaging, have contributed to the extensive application of FISH in monitoring microbes in complex environments [19]. One advantage of FISH, along with accuracy and adaptability, is the possibility to combine several oligonucleotide probes. FISH and derivative techniques are therefore ideal when it is necessary to detect multiple target microorganisms in the same samples [20]. In addition, FISH can be combined to standard detection methods like Indirect Immunofluorescence Antibody Assay (IFA), thus providing a better detection of targets [21,22]. It also represents a useful alternative when antibodies are unavailable or inefficient for a given organism. Few studies have described the use of FISH techniques to monitor different virus taxa [23-25] and no probes are as yet available for DENV. For these reasons, the aim of the study was to develop a FISH-based method, from the design of oligonucleotide probes to the final detection of the four DENV serotypes, including the widest possible range of DENV isolates.

**Methods**

**Ethics statement**

Anti-DENV hyper-immune ascetic fluid, used as primary antibodies in virus titration assays, was produced in accordance with French and European regulations on care and protection of laboratory animals at the Institut Pasteur that has accreditation from the French Ministry of Agriculture [see permit numbers at http://webcampus.pasteur.fr/jcms/c_97619/agreements-des-animaleries]. This study was approved by the relative IACUC at the Institut Pasteur.

**Probe design**

Probe design was based on the method of Jabado *et al.* [26], modified as follows. Briefly, the 3' and 5' untranslated regions (UTR), and coding regions of the DENV genome were recovered from GenBank (release 101, issue date 28, September 2009) [27]. Pfam-A was used to group the selected protein sequences into families according to domain similarity [28]. NCR sequences or those not grouped in Pfam-A families were clustered by CD-Hit [29] at a similarity threshold of 80%. For protein sequence motifs, the most conserved non-overlapping regions of 23 amino acids in length were selected using the statistics of the hidden Markov model and the motifs were mapped to their underlying nucleic sequences.
From the resulting database, sequences of candidate probes were shortlisted using the following criteria to maximize specificity: melting temperature ≥ 65°C; GC content between 40% and 60%; no homopolymer of 5 or more of the same nucleotide; no repeats of 10 or more nucleotides; and stem loop length ≤ 11nt. The specificity of all selected sequences was checked using the Basic Local Alignment Search tool (BLAST) querying the NCBI nucleotide database [30]. To further optimize hybridization, only sequences (maximum length, 60 nucleotides) showing a 75% overall similarity or forming 15 consecutive base pairs with a target sequence were synthesized (Life Technologies, Saint-Aubin, France). Entropy, cross-hybridization, and the absence of possible secondary structure, like hairpins, were checked using the online tool DINAMELT [31].

## Viruses

The dengue strains DENV-1 FGA/89, DENV-2 Jam, DENV-3 PaH88/881 and DENV-4 63632 were obtained from the Centre de Ressources Biologiques de l'Institut Pasteur (CRBIP, Paris, France). DENV-2 Bangkok, YFV and WNV strains were provided by the Virology Department of Institut Pasteur (Paris, France). Details of the virus strains are listed in Table 1. Viral stocks were produced on *Aedes* cell lines as previously described [32-36].

## Cell culture and virus infection

The C6/36 cell line derived from *Aedes albopictus* larvae [39] was grown at 28°C in Leibovitz's 15 (L-15) medium (Life Technologies) containing 10% foetal bovine serum (FBS) (PAA, Les Mureaux, France), 50 units/mL penicillin, 50 µg/mL streptomycin and 1X [7.5 mg/L Glycine, 8.9 mg/L L-Alanine, 13.2 mg/L L-Aspargine, 13.3 mg/L L_Aspartic acid, 14.7 mg/L L-Glutamic acid, 11.5 mg/L L-Proline, 10.5 mg/L L-Serine] non essential amino acids (Life Technologies). Twenty-four hours before virus infection, 5 × 10⁵ cells were allowed to attach to a sterile cover slip in shell vials (Sterilin, Newport, United Kingdom). Cell samples were then infected in triplicate with each DENV serotype or YFV and WNV strains at a multiplicity of infection (MOI) of 3. Uninfected cells were used as negative controls. Virus stocks were diluted

in appropriate volumes of L-15 medium supplemented with 2% FBS, and layered onto 80%-confluent cell monolayers for 1 hr at 28°C. After virus adsorption the inoculum was removed, 1 mL of medium with 2% FBS was added, and cells were incubated at 28°C. At 5 days post-infection (pi), supernatants were harvested and stored at -80°C for virus titration. Cells were washed once with PBS and fixed for 20 min at room temperature in freshly prepared 4% formaldehyde (Sigma-Aldrich, Lyon, France) in PBS, then rinsed three times in PBS.

To control the replication of the different virus strains used, 1 × 10⁶ cells were inoculated into 6-well plates and incubated at 28°C two days before infection. Virus infection in duplicate at a MOI of 3 was done as described above.

## Mosquito rearing and oral infection

The mosquito *Ae. albopictus* ALPROV originating from La Reunion was reared in standard conditions as reported [40]. For experimental infections, 1 mL of DENV-2 suspension (Bangkok strain) was mixed with 2 mL of washed rabbit erythrocytes (New Zealand White, Charles River) supplemented with ATP at final concentration of 5 mM (Sigma-Aldrich). Seven-day-old female mosquitoes, starved for 24h, were fed with infectious blood at a titer of 10⁷.⁵ FFU (Fluorescent Focus Units) per mL from a glass feeder as described [41]. Females fed with non-infected blood were used as controls. Fully engorged females were transferred to cardboard containers at 28 ± 1°C and fed with 10% sucrose. At day 14 pi, females were sacrificed and surface-disinfected in 70% ethanol and rinsed twice in sterile PBS. Salivary glands were removed from insects by dissection under a binocular microscope then deposited on a sterile glass cover slip previously coated with 40 µL of 0.01% poly-L-lysine (Sigma-Aldrich) in PBS. Salivary gland samples were fixed for 20 min in freshly prepared 4% formaldehyde in PBS in a shell vial, then washed 3 times in PBS and hybridized to probes as described below.

## Fluorescence in situ hybridization

PBS was removed from fixed cells or tissues (as above) and 1 mL of hybridization buffer (5X [750 mM NaCl,

<table><caption>**Table 1 Strains of *Flavivirus* used in this study**</caption><thead><tr><th>Genus</th><th>Virus</th><th>Strain</th><th>Locality</th><th>Year</th><th>Sample</th><th>GenBank accession number</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="7">Flavivirus</td><td>Dengue serotype 1</td><td>FGA/89</td><td>French Guiana</td><td>1989</td><td>Human</td><td>AF226687.2</td><td>[32]</td></tr><tr><td>Dengue serotype 2</td><td>Jam/N.1409</td><td>Jamaica</td><td>1983</td><td>Human</td><td>M20558.1</td><td>[33]</td></tr><tr><td>Dengue serotype 2</td><td>Bangkok</td><td>Thailand</td><td>1974</td><td>Human</td><td>Unavailable</td><td>[34]</td></tr><tr><td>Dengue serotype 3</td><td>PaH881/88</td><td>Thailand</td><td>1988</td><td>Human</td><td>S67858.1</td><td>[35]</td></tr><tr><td>Dengue serotype 4</td><td>63 632</td><td>Senegal</td><td>1983</td><td>Human</td><td>Unavailable</td><td>[36]</td></tr><tr><td>Yellow fever virus</td><td>Unavailable</td><td>Senegal</td><td>1979</td><td>Human</td><td>Unavailable</td><td>[37]</td></tr><tr><td>West Nile virus</td><td>Unavailable</td><td>France</td><td>2001</td><td>Horse</td><td>AF418554.1</td><td>[38]</td></tr></tbody></table>
75 mM Na-citrate, pH 7] SSC (Euromedex), 50% formamide, 200 mg/mL dextran sulfate, 250 µg/mL poly(A), 250 µg/mL salmon sperm DNA, 0.1 M dithiothreitol (DTT), 0.5X Denhardt's solution (Sigma-Aldrich), 250 µg/mL tRNA) containing 10 ng of each DENV probe, labeled at the 5' end with AlexaFluor® 488, was added. After incubation, the hybridization buffer was discarded and the samples were rinsed once in 1X [150 mM NaCl, 15 mM Na-citrate, pH 7] SSC, 10 mM DTT at room temperature. Further washes were done at 55°C for 15 min each, twice in 1X [150 mM NaCl, 15 mM Na-citrate, pH 7] SSC, 10 mM DTT and twice in 0.5X [75 mM NaCl, 7.5 mM Na-citrate, pH 7] SSC, 10 mM DTT. Finally, samples were rinsed three times in PBS, and each coverslip was carefully taken from the shell vial and mounted on a glass slide with 2.5 µL of DAPI (4', 6'-diamidino-2-phenylindole, dihydrochloride) at 1 µg/mL in glycerol/PBS (v/v). Slides were stored overnight at 4°C in the dark before microscopic observation.

## Fluorescence microscopy

Slides were viewed under an epifluorescence (Axio Imager Z1, Zeiss) or a confocal microscope (LSM510, Zeiss). Exposure time for each laser (to excite DAPI and AlexaFluor® 488) was standardized among samples. Images for each laser were taken separately then merged using the free-access software ImageJ MacBio-photonics (release 1.46, 32-bit, downloaded from www.rsb.info.nih.gov/ij/).

## Virus titration

Fluorescent focus assays (FFA) were used to estimate virus infectious titer on C6/36 cells. Two days before infection, $3 \times 10^5$ cells were placed in 96-well microplates and allowed to grow at 28°C. Confluent monolayers were infected with 50 µL of 10-fold serial dilutions of viral suspension in L-15 medium supplemented with 2% FBS. To allow viral adsorption, the microplates were incubated for 1 h at 28°C in 2% FBS L-15 medium with gentle shaking every 15 min. Then an overlay medium (150 µL) composed of L-15 medium with 10% (v/v) FBS and 3.2% (v/v) carboxymethyl cellulose (VWR, Pessac, France), was added. After 5 days at 28°C, cells were fixed by overlaying 100 µL of 4% formaldehyde in PBS for 20 min at room temperature. All the suspension was then gently removed and fixed cells were washed three times in PBS. For primary antibody staining, cells were incubated with mouse hyper-immune ascetic fluid (diluted 1:100 in PBS) specific to each virus for 45 min at 37°C. After three washes with PBS, anti-mouse IgG FITC conjugate (Bio-Rad, Marnes-La-Coquette, France), diluted 1:80 in PBS, was added for 45 min at 37°C. Cells were then rinsed three times in PBS and observed with an inverted fluorescent microscope (Zeiss) equipped with a FITC filter.

Fluorescent foci of infected cells were counted under a 10x objective and virus titers were expressed as the number of FFU per mL [42].

## RNA extraction, reverse transcription and diagnostic PCR

At 5 days pi, supernatants from infected cells in 6-well plates were removed. Cells were harvested and pelleted using a tabletop centrifuge, then stored at -80°C until use. Total RNA was obtained using the Qiagen RNeasy Mini Kit (Qiagen, Courtaboeuf, France), according to the manufacturer's recommendations, first crushing the cell pellet with a pestle for 30 s in 350 µL RLT buffer. Residual DNA was eliminated using the Turbo DNA-free kit as recommended by the manufacturer (Life Technologies).

RNA (100 ng) was reverse transcribed using 400 U SuperScript III reverse transcriptase (Life Technologies) and 200 ng of random primers in a 50-µL reaction volume according to the manufacturer's recommendations. The resulting cDNA samples were treated with 10 U/µL RNase H (Life Technologies) for 20 min at 37°C, then purified using a QIAquick PCR purification kit according to manufacturer's instructions (Qiagen).

To detect virus RNA, diagnostic PCR was done with *Flavivirus*-specific primers PF1S (5'-TGYRTBT AYAACATGATGGG-3') and PF2R-bis (5'-GTGTCCCA ICCNGCNGTRTC3') targeting an approximately 230-bp fragment of the NS5 gene [43]. The 25-µL reaction mixture contained 40 ng of cDNA template, 0.5 U Taq polymerase, [20 mM Tris-HCl (pH 8.4), 500 mM KCl] reaction buffer (both from Life Technologies), 1.5 mM MgCl2, 200 µM of each dNTP and 200 nM of each primer. PCR was performed in a T1 Thermocycler (Biometra) as follows: 95°C for 3 min; 40 cycles of 94°C for 1 min, 50°C for 1 min, 72°C for 1 min; and 72°C for 10 min. PCR products were checked by electrophoresis through 1% agarose gel alongside a low-range DNA ladder (Fermentas, Courtaboeuf, France). Fragments of expected sizes were sequenced (Sanger sequencing).

## Results and discussion

### In silico analysis of selected DENV probes

The probe design strategy allowed a set of ten probes that fitted the criteria listed above to be obtained. We selected two probes with a GC content close to 50% and a lower number of hairpins, while targeting the broadest range of DENV isolates. Two oligonucleotide probes, designated DENV-ProbeA and DENV-ProbeB, which target respectively a fragment of a 3' untranslated region (UTR) and a fragment of the non-structural 3 (NS3) protein-encoding gene were first selected (Table 2). When analyzed against the NCBI nucleotide collection using BLASTn, with a word size of 7, an expected threshold of 1,000 and a minimal e-value of 0.05, the
<table><caption>Table 2 DENV probe sequences</caption><thead><tr><th></th><th>Sequence (5' to 3')</th><th>GC%</th><th>Tm (°C)</th><th>Hairpin DG</th></tr></thead><tbody><tr><td>DENV-ProbeA</td><td>GCCGGATTAAGCCATAGTACGGTAAGAGCTATGCTGCCTGTGAGCCCCGTCTGAGGACGT</td><td>57</td><td>56.7</td><td>-2</td></tr><tr><td>DENV-ProbeB</td><td>AGAAAATGACCAGTACATATTCACGGGCCAGCCTCTCAACAATGACGAGGACCATGCTCA</td><td>48</td><td>48.3</td><td>-1.8</td></tr><tr><td>DENV-ProbeC</td><td>ATGGTGCTTCACTGGGGAAAGAAATAACCAAATTCTAGAAGAAAACATGGAGGTTGAAAT</td><td>37</td><td>36.7</td><td>-0.9</td></tr></tbody></table>

DENV-Probes A and B sequences matched with all DENV serotypes (Additional file 1: Figure S1). These results indicated that most of the sequences for each serotype present in GenBank would be detected by at least one of the two probes, except for DENV-4. Indeed, the specificity of the two probes for the DENV-4 serotype was relatively low, and matched few DENV-4 isolates. Although this result might be unexpected as there is relatively little genomic divergence between DENV serotypes [44], we found that DENV-4 is the serotype with the fewest sequences available in GenBank, which could partly explain the BLASTn results. To detect as many DENV isolates as possible, the DENV-ProbeC, which targets a fragment of the non-structural 2 (NS2) protein-encoding gene and matches with all sequenced complete genomes of DENV-4 (Table 3, Additional file 2: Figure S1), was added to the initial set of probes.

Using the BLASTn parameters described above, the three DENV probes were matched against the YFV (taxid: 11089), WNV (taxid: 11082), JEV (taxid: 11072), chikungunya virus (CHIKV, taxid: 337124) and *Aedes* (taxid: 7158) and no sequences were retrieved. These results indicated that *in silico*, no hybridization with these viruses could occur.

## Detection of DENV serotypes in infected cell cultures

The FISH method using the three DENV-ProbeA, DENV-ProbeB, and DENV-ProbeC probes together was first tested using the well-characterized arbovirus-permissive *Ae. albopictus* C6/36 cell line. The use of three probes simultaneously may lead to a considerable increase in the hybridizing signal, with no incidence on the level of the background signal [45]. After infection at

a MOI of 3, green fluorescent dots corresponding to the hybridized probes with DENV RNA were observed in the cytoplasm of cells infected with each of the four DENV serotypes at 5 days pi (Figure 1). No green fluorescent signal was observed in the cytoplasm of uninfected control cells. Nuclei were strongly stained blue with DAPI with, in some cases, a faint green autofluorescence (Figure 1). This hybridization pattern was expected as members of the genus *Flavivirus* are known to replicate almost exclusively in the cytoplasm of infected cells [46,47]. Overall, these observations validate the choice of probes and the hybridization protocol.

To assess probe specificity towards DENV, we also infected cells with genetically closely related *Flavivirus* YFV and WNV, then hybridized with the three DENV-ProbeA, DENV-ProbeB, and DENV-ProbeC probes together as described above. As expected from *in silico* analyses, no green fluorescence was detected at day 5 pi, as was observed for uninfected cells (Figure 1). *Flavivirus* replication kinetics in C6/36 is known to reach the plateau phase at 5 or 6 days pi [48,49]. This shows that the DENV probes do not readily cross-hybridize with the most closely related viruses in insect cells.

To ensure that the absence of signal in the above YFV and WNV samples was not an artifact of defective viral infection, supernatants from the same cell cultures previously used in FISH were titrated for viruses. The infectious titers reached $5.6 \times 10^{11}$ FFU/mL for WNV, $2.2 \times 10^{11}$ FFU/mL for YFV and those of DENV1 to DENV-4 were comprised between $1.4 \times 10^5$ FFU/mL (positive controls). No fluorescent foci were counted for uninfected cell supernatants. In addition, the presence of viral RNA was ascertained by reverse transcription and PCR amplification using genus-specific primers. Bands of the expected size (230 bp) were obtained for all the six viruses from day 5 pi cultures (Figure 2) and sequencing of PCR products (data not shown) confirmed they belonged to the respective viruses tested, indicating that replication of each virus was productive in C6/36 infected cells.

<table><caption>Table 3 Number of isolates targeted by the three DENV probes simultaneously</caption><thead><tr><th></th><th>DENV-1</th><th>DENV-2</th><th>DENV-3</th><th>DENV-4</th></tr></thead><tbody><tr><td>Isolates<sup>a</sup> (%)</td><td>1279 (98.8)<sup>b</sup></td><td>885 (99.7)<sup>b</sup></td><td>654(99.8)<sup>b</sup></td><td>97 (100)<sup>b</sup></td></tr><tr><td>e-value max</td><td>9x10<sup>-23</sup></td><td>9x10<sup>-5</sup></td><td>9x10<sup>-23</sup></td><td>9x10<sup>-23</sup></td></tr><tr><td>e-value min</td><td>1x10<sup>-3</sup></td><td>3x10<sup>-3</sup></td><td>1x10<sup>-14</sup></td><td>1x10<sup>-21</sup></td></tr><tr><td>Query max</td><td>100</td><td>98</td><td>100</td><td>100</td></tr><tr><td>Query min</td><td>90</td><td>85</td><td>98</td><td>98</td></tr><tr><td>Identity max</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Identity min</td><td>98</td><td>94</td><td>98</td><td>73</td></tr></tbody></table>

## Monitoring of DENV in mosquito tissues

The virus infection process in mosquitoes is very different from that in cell culture. To evaluate the usefulness of the DENV FISH probes, they were used to localize DENV in host tissues. Females of *Ae. albopictus* ALPROV from La Reunion fed with a DENV-2 Bangkok

<footnote>aComplete genome sequences only.</footnote>

<footnote>bNCBI GenBank nucleotide database, release 189 of 15th April 2012.</footnote>
<figure><img src="image_2.png" /><figcaption>**Figure 1** Specific detection of DENV without cross-hybridization towards closely related *Flavivirus*. Cells were infected with the most closely related *Flavivirus* YFV and WNV. DENV-1, DENV-2, DENV-3, DENV-4 were used as positive controls. FISH was performed using the three selected probes simultaneously at day 5 post-infection. Positive hybridizing signals (green) are seen in the cytoplasm of C6/36 cells infected with DENV-1 to DENV-4. No hybridizing signals were visible in cells infected with YFV and WNV or in uninfected cells. Host cell nuclei are stained with DAPI. Bar, 10 µm.</figcaption></figure>

strain infectious blood-meal were dissected at 14 days pi. The DENV probes were designed to match with the largest number of DENV isolates as possible, within each serotype. As a consequence, we decided to use the Bangkok isolate of DENV-2 (Table 1) to infect *Ae. albopictus*, as we had experimental data on its replication kinetic in this mosquito strain system in contrast to previously used DENV strains [42,50].

The dissected salivary glands of infected females were hybridized with the three DENV-Probes, as described. Confocal microscopic images showed dots indicative of probe hybridization in the lateral lobes of DENV-infected females at 14 days pi (Figure 3). In contrast, no significant fluorescent signals were observed in organs of uninfected mosquitoes used as negative controls (Figure 3). This result confirmed that our probes
<figure><img src="image_3.png" /></figure>

**Figure 2** Diagnostic PCR of viral RNA in C6/36 cells. C6/36 cells were infected with DENV-1 to DENV-4, YFV or WNV and 5 days later RNA was extracted from cells and reverse transcribed. PCR was performed on the cDNA obtained to amplify a 230-bp fragment of the NS5 gene, conserved among *Flavivirus*. Fragments of the expected size were obtained for all the six viruses, but not for uninfected cells. Ladder Mass Ruler DNA Low Range (Fermentas) was used as size marker (bp).

could be used to detect DENV-2 in *Ae. albopictus* salivary glands after oral infection of the vector.

In the principal DENV vector *Ae. aegypti*, a period of 7 to 10 days post-infection is necessary to reach

maximum viral replication, allowing the virus particles to invade salivary glands [17]. *Ae. albopictus* is less competent for DENV, the incubation period to reach high RNA levels is longer and close to 14 days [50,51]. Moreover, the density of infectious DENV particles in the salivary glands was found to be weak in *Ae. albopictus* ALPROV strain, due to *Wolbachia* infection (Mousson *et al*., submitted). Despite this constraint, we were able to detect viral RNA in *Ae. albopictus* salivary glands at 14 days pi. This result shows that FISH is an efficient method that can be used even with complex material like mosquito organs.

To detect DENV *in situ*, the indirect Immunofluorescence Antibody Assay (IFA) is the standard method, with serotype specific antibodies commercially available [52]. However, IFA method targets antigenic proteins at the surface of viral particles whereas the FISH technique is based on the detection of viral RNA, two different labels of the viral cycle. The FISH method allows monitoring of DENV replicating genome during infection process and may represent a complementary method to IFA. Moreover, the literature provides numerous studies using FISH and IFA in combination [22,53,54]. In addition, we emphasize that FISH could be an alternative method to detect arboviruses in host tissues, also

<figure><img src="image_4.png" /></figure>

**Figure 3** FISH detection of viral RNA in salivary glands of *Aedes albopictus* by confocal microscopy. FISH was carried out on salivary glands dissected from *Ae. albopictus* females at 14 days post-infection with blood-meals containing DENV-2 Bangkok strain, using the three DENV-Probes simultaneously. Viral RNA is detected (green) in the distal zone of the lobe close to the salivary duct. No signal was detected in control females engorged with an uninfected blood-meal. Bar, 500 µm. A global view of salivary glands is provided in the supplementary Figure S2.
offering to circumvent the discontinuity of antibodies
used in immunofluorescent assays.

Conclusions

In this study, oligonucleotide FISH was developed and
used for the first time to detect replicating genomic
DENV RNA. Viral RNAs were detected in both infected
cell lines and salivary glands of the mosquito vector
*Ae. albopictus*. As mentioned, *Ae. albopictus* is a less
efficient vector of DENV than *Aedes aegypti*. Recent
work has established that *Wolbachia*, a bacterial endo-
symbiont naturally present in *Ae. albopictus*, influences
vector competence by interfering with viral infection
and dissemination in mosquitoes [40,55]. This FISH ap-
proach could be useful to identify DENV tropism in the
less efficient vector *Ae. albopictus*. Furthermore, it could
help to explain the bacterial influence on DENV dissem-
ination, especially as we have already detected *Wolbachia*
in mosquito tissues using the same FISH-based protocol
presented here [56]. This could improve our comprehen-
sion of mosquito vectorial competence for DENV.

DENV replication begins with the synthesis of a nega-
tive intermediate RNA, which appears transiently
double-stranded RNA (dsRNA) for production of posi-
tive strands used in virion assembly [57]. dsRNA is con-
sidered as the true replicative intermediate form of
DENV, and can be detected with specific antibodies [58].
The FISH technique could be used to discriminate posi-
tive and negative strands by designing specific probes,
and eventually couple to IFA in order to detect every
intermediate as well as viral proteins [59].

Cases of co-infection with multiple DENV serotypes
[60] and chikungunya virus were reported in human
[61,62] and in *Ae. albopictus* [63], the latter having
the ability to simultaneously deliver DENV and CHIKV
in its saliva [63]. These multiple infections, together
with potential multipartite interactions, emphasize the
importance in some circumstances of monitoring more
than one infectious agent at a time [64]. This work pro-
vides a method to design oligonucleotide probes specific
for a given DNA/RNA template, which may be useful
for microorganisms for which no antibodies are available
yet, as well as a unique hybridization protocol that has
already been used to detect other types of microorga-
nisms [56]. In this context, FISH could be an adapted
alternative method for monitoring multiple biological
agents in a given tissue.

**Additional files**

**Additional file 1: Figure S1.** Alignment of DENV-Probes on genomic RNA sequence of DENV isolates. ClustalW Multiple Alignment was performed to align DENV-ProbeA, DENV-ProbeB and DENV-ProbeC against some well-targeted DENV RNA sequences. As mentioned in the

text, very few isolates of DENV-4 were targeted by probes A and B. The mismatch numbers for DENV-ProbeA with DENV-4 were high and distorted alignment, so DENV-4 was removed from the analysis. As the DENV-ProbeC specifically targets serotype 4, only alignment on DENV-4 sequence isolates is presented.

**Additional file 2: Figure S2.** Epifluorescence microscopy showing morphology of *Aedes albopictus* salivary glands. The cell nuclei appear in green after labelling by SYTOX. SD, salivary duct; LL: Lateral Lobe; ML: Median Lobe. Bar, 500 µm.

Abbreviations

Arbovirus: Arthropod borne virus; DAPI: 4', 6'-diamidino-2-phenylindole, dihydrochloride; DENV: Dengue virus; dsRNA: Double-stranded RNA;
DTT: Dithiothreitol; EIP: Extrinsic incubation period; FBS: Foetal bovine serum;
FFA: Fluorescent focus assay; FFU: Fluorescent forming unit;
FISH: Fluorescence *In Situ* Hybridization; IFA: Indirect immunofluorescence
antibody assay; JEV: Japanese encephalitis virus; L-15: Leibovitz's 15 medium;
LTR: Long terminal repeat; MOI: Multiplicity of infection; NCR: Non coding
region; PBS: Phosphate buffered saline; PI: Post infection; SSC: Saline-sodium
citrate; TBEV: Tick-borne encephalitis virus; UTR: Untranslated region;
WNV: West-nile virus; YFV: Yellow fever virus.

Competing interests

The authors declare that they have no competing interests.

Author's contributions

VR, CVM, and PM conceived the work. VR, MV, KZ, CVM and PM designed and performed the experiments. VR, MV, KZ, CLL, CVM and PM analyzed the results. VR, CVM, PM wrote the paper in collaboration with other authors. All authors read and approved the final version of the manuscript.

Acknowledgements

We thank Marie Vazeille and Anna-Bella Failloux at the Institut Pasteur in Paris for supplying us with the YFV and WNV strains. We also thank Nelly Burlet and Claire Prigent-Combaret for assistance with microscopy. We acknowledge the contribution of the BSL3 platform of SFR BioSciences Gerland Lyon Sud (UMS3444/US8) as well as the DTAMB platform and the Centre Technologique des Microstructures (CTµ) of the FR41 Bio-Environment and Health (University Lyon 1), and the Lyon Science Transfert (University of Lyon 1). VR was funded by a PhD fellowship from the French Ministère de l'Éducation Nationale. This work was partially funded by the grants ANR-2010-BLAN-170101 (ImmunSymbArt), ACIP A-10-2009 and FRB-CD-AOOI-07-12, and was carried out within the framework of the GDRIs "Biodiversity and Infectious Diseases" and "Biodiversité et Développement Durable".

Author details

¹UMR CNRS 5557 Ecologie Microbienne, Université Lyon 1, 43 boulevard du 11 Novembre 1918, Villeurbanne cedex 69622, France. ²PRABI, Pôle Rhône-Alpes de Bioinformatique, Villeurbanne, France. ³Institut Pasteur, Department of Virology, Arboviruses and Insect Vectors, 25–28 rue du Dr Roux, Paris cedex 15 75724, France.

Received: 24 August 2012 Accepted: 25 October 2012
Published: 30 October 2012

References

1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW: **Dengue: a continuing global threat.** *Nat Rev Microbiol* 2010, **8**:S7–16.

2. Dengue: guidelines for diagnosis, treatment, prevention and control-new edition World Health Organization. Geneva; 2009 http://whqlibdoc.who.int/ publications/2009/9789241547871_eng.pdf.

3. Fauquet CM, Fargette D: International Committee on Taxonomy of Viruses and the 3,142 unassigned species. *ViroJ* 2005, **2**:64.

4. Sabin AB: Research on dengue during World War II. *Am J Trop Med Hyg* 1952, **1**:30–50.
5. Hammon WM, Rudnick A, Sather GE: Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. *Science* 1960, **131**:1102-1103.

6. Rico-Hesse R: Molecular evolution and distribution of dengue virus types 1 and 2 in nature. *Virology* 1990, **174**:479-493.

7. Diallo M, Ba Y, Sall AA, Diop OM, Ndione JA, Mondo M, Girault L, Mathiot C: Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations. *Emerging Infect Dis* 2003, **9**:362-367.

8. Diallo M, Sall AA, Moncayo AC, Ba Y, Fernandez Z, Ortiz D, Coffey LL, Mathiot C, Tesh RB, Weaver SC: Potential role of sylvatic and domestic African mosquito species in dengue emergence. *Am J Trop Med Hyg* 2005, **73**:445-449.

9. Robin Y, Cornet M, Heme G, Le Gonidec G: Isolement du virus de la dengue au Sénégal. *Annales de l'Institut Pasteur / Virologie* 1980, **131**:149-154.

10. Vasilakis N, Cardosa J, Hanley KA, Holmes EC, Weaver SC: Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. *Nat Rev Microbiol* 2011, **9**:532-541.

11. Kamgang B, Nchoutpouen E, Simard F, Paupy C: Notes on the blood-feeding behavior of *Aedes albopictus* (*Diptera: Culicidae*) in Cameroon. *Parasit Vectors* 2012, **5**:57.

12. Rosen L, Gubler D: The use of mosquitoes to detect and propagate dengue viruses. *Am J Trop Med Hyg* 1974, **23**:1153-1160.

13. Johnson BW, Russell BJ, Lanciotti RS: Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. *J Clin Microbiol* 2005, **43**:4977-4983.

14. Fry SR, Meyer M, Semple MG, Simmons CP, Sekaran SD, Huang JX, McElnea C, Huang C-Y, Valks A, Young PR, Cooper MA: The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a Combined Antigen and Antibody Testing Approach. *PLoS Negl Trop Dis* 2011, **5**:e1199.

15. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, Enria DA, Farrar J, Gubler DJ, Guzman MG, Halstead SB, Hunsperger E, Kliks S, Margolis HS, Nathanson CM, Nguyen VC, Rizzo N, Vázquez S, Yoksan S: Evaluation of diagnostic tests: dengue. *Nat Rev Microbiol* 2010, **8**:30-38.

16. Jessie K, Fong MY, Devi S, Lam SK, Wong KT: Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. *J Infect Dis* 2004, **189**:1411-1418.

17. Salazar MI, Richardson JH, Sánchez-Vargas I, Olson KE, Beaty BJ: Dengue virus type 2: replication and tropisms in orally infected *Aedes aegypti* mosquitoes. *BMC Microbiol* 2007, **7**:9.

18. Rudkin GT, Stollar BD: High resolution detection of DNA-RNA hybrids in *situ* by indirect immunofluorescence. *Nature* 1977, **265**:472-473.

19. Wagner M, Haider S: New trends in fluorescence *in situ* hybridization for identification and functional analyses of microbes. *Curr Opin Biotechnol* 2012, **23**:96-102.

20. Volpi EV, Bridger JM: FISH glossary: an overview of the fluorescence *in situ* hybridization technique. *Biotechniques* 2008, **45**:385-386. 388, 390 passim.

21. Lucy FE, Graczyk TK, Tamang L, Miraflor A, Minchin D: Biomonitoring of surface and coastal water for *Cryptosporidium*, *Giardia*, and human-virulent microsporidia using molluscan shellfish. *Parasitol Res* 2008, **103**:1369-1375.

22. Smith Jj, Gunasekera Ts, Barardi Crm, Veal D, Vesey G: Determination of *Cryptosporidium parvum* oocyst viability by fluorescence *in situ* hybridization using a ribosomal RNA-directed probe. *J Appl Microbiol* 2004, **96**:409-417.

23. Brass V, Gosert R, Moradpour D: Investigation of the hepatitis C virus replication complex. *Methods Mol Biol* 2009, **510**:195-209.

24. Uphoff CC, Denkmann SA, Steube KG, Drexler HG: Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines. *J Biomed Biotechnol* 2010, **2010**:904767.

25. Kobiler O, Brodersen P, Taylor MP, Ludmir EB, Enquist LW: Herpesvirus replication compartments originate with single incoming viral genomes. *MBio* 2011, **2**.

26. Jabado OJ, Liu Y, Conlan S, Quan PL, Hegyi H, Lussier Y, Briese T, Palacios G, Lipkin WI: Comprehensive viral oligonucleotide probe design using conserved protein regions. *Nucleic Acids Res* 2008, **36**:e3.

27. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL: GenBank. *Nucleic Acids Res* 2008, **36**:D25-30.

28. Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, Hotz H-R, Ceric G, Forslund K, Eddy SR, Sonnhammer ELL, Bateman A: The Pfam protein families database. *Nucleic Acids Res* 2008, **36**:D281-288.

29. Li W, Godzik A: Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. *Bioinformatics* 2006, **22**:1658-1659.

30. Kanz C, Aldebert P, Althorpe N, Baker W, Baldwin A, Bates K, Browne P, van den Broek A, Castro M, Cochrane G, Duggan K, Eberhardt R, Faruque N, Gamble J, Diez FG, Harte N, Kulikova T, Lin Q, Lombard V, Lopez R, Mancuso R, McHale M, Nardone F, Silventoinen V, Sobhany S, Stoehr P, Tuli MA, Tzouvara K, Vaughan R, Wu D, Zhu W, Apweiler R: The EMBL Nucleotide Sequence Database. *Nucleic Acids Res* 2005, **33**:D29-33.

31. Markham NR, Zuker M: DINAMelt web server for nucleic acid melting prediction. *Nucleic Acids Res* 2005, **33**:W577-581.

32. Santos CN Dd, Frenkiel MP, Courageot MP, Rocha CF, Vazeille-Falcoz MC, Wien MW, Rey FA, Deubel V, Desprès P: Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. *Virology* 2000, **274**:292-308.

33. Deubel V, Kinney RM, Trent DW: Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. *Virology* 1986, **155**:365-377.

34. Vazeille-Falcoz M, Mousson L, Rodhain F, Chungue E, Failloux AB: Variation in oral susceptibility to dengue type 2 virus of populations of *Aedes aegypti* from the islands of Tahiti and Moorea, French Polynesia. *Am J Trop Med Hyg* 1999, **60**:292-299.

35. Chungue E, Deubel V, Cassar O, Laille M, Martin PM: Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. *J Gen Virol* 1993, **74**(Pt 12):2765-2770.

36. Chungue E, Cassar O, Drouet MT, Guzman MG, Laille M, Rosen L, Deubel V: Molecular epidemiology of dengue-1 and dengue-4 viruses. *J Gen Virol* 1995, **76**:1877-1884.

37. Rodhain F, Hannoun C, Jousset FX, Ravisse P: Isolation of the yellow fever virus in Paris from 2 imported human cases. *Bull Soc Pathol Exot Filiales* 1979, **72**:411-415.

38. Murgue B, Murri S, Zientara S, Durand B, Durand JP, Zeller H: West Nile outbreak in horses in southern France, 2000: the return after 35 years. *Emerging Infect Dis* 2001, **7**:692-696.

39. Igarashi A: Isolation of a Singh's *Aedes albopictus* cell clone sensitive to Dengue and Chikungunya viruses. *J Gen Virol* 1978, **40**:531-544.

40. Mousson L, Martin E, Zouache K, Madec Y, Mavingui P, Failloux AB: *Wolbachia* modulates Chikungunya replication in *Aedes albopictus*. *Mol Ecol* 2010, **19**:1953-1964.

41. Zouache K, Michelland RJ, Failloux A-B, Grundmann GL, Mavingui P: Chikungunya virus impacts the diversity of symbiotic bacteria in mosquito vector. *Mol Ecol* 2012, **21**:2297-2309.

42. Blagrove MSC, Arias-Goeta C, Failloux A-B, Sinkins SP: *Wolbachia* strain wMel induces cytoplasmic incompatibility and blocks dengue transmission in *Aedes albopictus*. *Proc Natl Acad Sci USA* 2012, **109**:255-260.

43. Moureau G, Temmam S, Gonzalez JP, Charrel RN, Grard G, de Lamballerie X: A real-time RT-PCR method for the universal detection and identification of flaviviruses. *Vector Borne Zoonotic Dis* 2007, **7**:467-477.

44. Vasilakis N, Weaver SC: The history and evolution of human dengue emergence. *Adv Virus Res* 2008, **72**:1-76.

45. Zwiglmaier K: Fluorescence *in situ* hybridisation (FISH)-the next generation. *FEMS Microbiol Lett* 2005, **246**:151-158.

46. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA: Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. *J Virol* 1997, **71**:6650-6661.

47. Grun JB, Brinton MA: Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity. *J Virol* 1987, **61**:3641-3644.

48. Lim PY, Louie KL, Styer LM, Shi PY, Bernard KA: Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. *Virology* 2010, **400**:93-103.

49. Pierro DJ, Salazar MI, Beaty BJ, Olson KE: Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation. *J Gen Virol* 2006, **87**:2263-2268.
50. Vazeille M, Rosen L, Mousson L, Failloux A-B: Low oral receptivity for dengue type 2 viruses of *Aedes albopictus* from Southeast Asia compared with that of *Aedes aegypti*. *Am J Trop Med Hyg* 2003, **68**:203–208.

51. Zhang M, Zheng X, Wu Y, Gan M, He A, Li Z, Liu J, Zhan X: Quantitative analysis of replication and tropisms of Dengue virus type 2 in *Aedes albopictus*. *Am J Trop Med Hyg* 2010, **83**:700–707.

52. Henchal EA, McCown JM, Seguin MC, Gentry MK, Brandt WE: Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. *Am J Trop Med Hyg* 1983, **32**:164–169.

53. Larsen P, Nielsen JL, Otzen D, Nielsen PH: Amyloid-Like Adhesins Produced by Floc-Forming and Filamentous Bacteria in Activated Sludge. *Appl Environ Microbiol* 2008, **74**:1517–1526.

54. Bednarska M, Bajer A, Sinski E, Girouard AS, Tamang L, Graczyk TK: Fluorescent in situ hybridization as a tool to retrospectively identify *Cryptosporidium parvum* and *Giardia lamblia* in samples from terrestrial mammalian wildlife. *Parasitol Res* 2007, **100**:455–460.

55. Moreira LA, Iturbe-Ornaetxe I, Jeffery JA, Lu G, Pyke AT, Hedges LM, Rocha BC, Hall-Mendelin S, Day A, Riegler M, Hugo LE, Johnson KN, Kay BH, McGraw EA, van den Hurk AF, Ryan PA, O'Neill SL: *A Wolbachia* symbiont in *Aedes aegypti* limits infection with dengue, Chikungunya, and Plasmodium. *Cell* 2009, **139**:1268–1278.

56. Zouache K, Voronin D, Tran-Van V, Mousson L, Failloux A-B, Mavingui P: Persistent *Wolbachia* and cultivable bacteria infection in the reproductive and somatic tissues of the mosquito vector *Aedes albopictus*. *PLoS One* 2009, **4**:e6388.

57. Lindenbach BD, Rice CM: Molecular biology of flaviviruses. *Adv Virus Res* 2003, **59**:23–61.

58. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CKE, Walther P, Fuller SD, Antony C, Krijnse-Locker J, Bartenschlager R: Composition and three-dimensional architecture of the dengue virus replication and assembly sites. *Cell Host Microbe* 2009, **5**:365–375.

59. Vyboh K, Ajamian L, Mouland AJ: Detection of viral RNA by fluorescence *in situ* hybridization (FISH). *J Vis Exp* 2012, **5**:e4002.

60. Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, Kabra SK, Broor S: Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi. *India. Virol J* 2008, **5**:1.

61. Hapuarachchi HAC, Bandara KBAT, Hapugoda MD, Williams S, Abeyewickreme W: Laboratory confirmation of dengue and chikungunya co-infection. *Ceylon Med J* 2008, **53**:104–105.

62. Schilling S, Emmerich P, Günther S, Schmidt-Chanasit J: Dengue and Chikungunya virus co-infection in a German traveller. *J Clin Virol* 2009, **45**:163–164.

63. Leroy EM, Nkoghe D, Ollomo B, Nze-Nkogue C, Becquart P, Grard G, Pourrut X, Charrel R, Moureau G, Ndjoyi-Mbiguino A, De-Lamballerie X: Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, 2007. *Emerging Infect Dis* 2009, **15**:591–593.

64. Sivaram A, Barde P, Gokhale M, Singh D, Mourya D: Evidence of co-infection of chikungunya and densonucleosis viruses in C6/36 cell lines and laboratory infected *Aedes aegypti* (L.) mosquitoes. *Parasit Vectors* 2010, **3**:95.

doi:10.1186/1756-3305-5-243

Cite this article as: Raquin et al.: Detection of dengue group viruses by fluorescence *in situ* hybridization. *Parasites & Vectors* 2012 **5**:243.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at
www.biomedcentral.com/submit

BioMed Central